American Trust decreased its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 27.5% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 18,665 shares of the company's stock after selling 7,063 shares during the quarter. American Trust's holdings in Procter & Gamble were worth $3,181,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in PG. Brighton Jones LLC raised its holdings in shares of Procter & Gamble by 51.5% during the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company's stock valued at $6,717,000 after purchasing an additional 13,617 shares in the last quarter. Bank Pictet & Cie Europe AG raised its holdings in shares of Procter & Gamble by 493.6% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 341,750 shares of the company's stock valued at $57,294,000 after purchasing an additional 284,174 shares in the last quarter. Triumph Capital Management raised its holdings in shares of Procter & Gamble by 102.7% during the 4th quarter. Triumph Capital Management now owns 9,400 shares of the company's stock valued at $1,576,000 after purchasing an additional 4,763 shares in the last quarter. Jefferies Financial Group Inc. raised its holdings in shares of Procter & Gamble by 8.2% during the 4th quarter. Jefferies Financial Group Inc. now owns 48,451 shares of the company's stock valued at $8,123,000 after purchasing an additional 3,667 shares in the last quarter. Finally, Lighthouse Investment Partners LLC bought a new position in shares of Procter & Gamble during the 4th quarter valued at $5,725,000. Hedge funds and other institutional investors own 65.77% of the company's stock.
Procter & Gamble Stock Performance
NYSE:PG opened at $159.12 on Tuesday. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $372.42 billion, a PE ratio of 24.44, a PEG ratio of 4.22 and a beta of 0.36. The firm's fifty day simple moving average is $156.41 and its 200 day simple moving average is $162.14. Procter & Gamble Company has a 1 year low of $149.91 and a 1 year high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.06. The company had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business's quarterly revenue was up 1.7% on a year-over-year basis. During the same period last year, the business posted $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, sell-side analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were given a $1.0568 dividend. This represents a $4.23 annualized dividend and a yield of 2.7%. The ex-dividend date was Friday, July 18th. Procter & Gamble's dividend payout ratio (DPR) is currently 64.82%.
Analyst Upgrades and Downgrades
A number of research analysts have recently weighed in on PG shares. Wells Fargo & Company cut their price target on shares of Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Evercore ISI restated an "in-line" rating and set a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. BNP Paribas reiterated an "outperform" rating and issued a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $170.00 target price (down from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Finally, Barclays set a $164.00 target price on shares of Procter & Gamble and gave the company an "equal weight" rating in a research note on Thursday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $175.12.
Get Our Latest Research Report on Procter & Gamble
Insider Buying and Selling
In other Procter & Gamble news, CEO Gary A. Coombe sold 10,194 shares of the firm's stock in a transaction on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total value of $1,612,283.04. Following the sale, the chief executive officer directly owned 34,978 shares in the company, valued at $5,532,120.48. This trade represents a 22.57% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Ma. Fatima Francisco sold 9,100 shares of the firm's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,431,157.00. Following the completion of the sale, the chief executive officer owned 27,295 shares in the company, valued at $4,292,684.65. This represents a 25.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 120,181 shares of company stock worth $18,918,012. 0.18% of the stock is currently owned by corporate insiders.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report